13 Cheap Stocks with Huge Upside Potential
He stated that the episode of the last six months showed just how brutally efficient the price discovery process is, in any market but especially the US stock market.
Novavax Inc (NVAX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Shah Capital Management Himanshu H. Shah | 11,131,846 | $71,355,133 | -1% | 14.58% |
| 2. | 67,827,000 | $63,209,114 | 1.11% | ||
| 3. | 30,750,000 | $27,997,875 | -12% | 0.72% | |
| 4. | Coatue Management Philippe Laffont | 3,836,986 | $24,595,080 | 0.11% | |
| 5. | D E Shaw D. E. Shaw | 3,260,908 | $20,902,420 | -44% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.50 | 1,000 | $6,500.00 | 14,473 | 2023-03-10 | Filing | |
| $7.04 | 2,000 | $14,088.00 | 13,473 | 2023-03-07 | Filing | |
| $7.48 | 3,000 | $22,453.50 | 11,473 | 2023-03-06 | Filing | |
| $139.64 | 700 | $97,748.00 | 2,800 | 2021-05-19 | Filing | |
| $48.83 | 1,500 | $73,245.00 | 1,500 | 2020-06-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.02 | 4,150 | $37,435.08 | 14,770 | 2024-12-13 | Filing | |
| $8.00 | 5,400 | $43,200.00 | 51,760 | 2024-12-31 | Filing | |
| $8.48 | 4,600 | $39,008.00 | 57,160 | 2024-12-24 | Filing | |
| $14.09 | 7,500 | $105,675.00 | 61,760 | 2024-06-21 | Filing | |
| $14.28 | 1,107 | $15,807.96 | 69,260 | 2024-06-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,695 | $72,726 | 0% | |
| 2. | 2,896 | $18,245 | 0% | |
| 3. | 1,033 | $6,508 | 0% | |
| 4. | 827 | $5,210 | 0% | |
| 5. | 756 | $4,763 | 0% |
News See All
Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating
Novavax Inc. (NASDAQ:NVAX) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 17, Citi initiated coverage of Novavax Inc.
13 Cheap Healthcare Stocks with Huge Upside Potential
On July 8, Kate Moore, Citi Wealth CIO, appeared on CNBC's 'Squawk Box' to talk about the recent rally in equities.
BofA Reiterates Hold Rating on Novavax (NVAX) Stock
The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from Sanofi during Q3 and an additional $50 million in the second half of 2025.
BTIG Maintains a Buy rating on Novavax (NVAX)
The approval marks a significant milestone for Novavax Inc. (NASDAQ:NVAX), aligning with the changing regulatory landscape after the pandemic.
JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News
On May 19, JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7.
FDA Clears Novavax, Inc. (NVAX)'s COVID-19 Vaccine with Usage Restrictions
Previously available under emergency use authorization for individuals aged 12 and up, the shot is now fully approved only for adults 65 and older, or for those between the ages of 12 and 64 who have ...
10 Unstoppable Stocks That Could Double Your Money
Generating significant returns and multiplying their money in the stock market remains a primary goal for most investors.
11 High-Risk High-Reward Growth Stocks To Buy Now
The stock market has an ever-changing environment, leaving investors constantly looking for opportunities that promise substantial returns for their investments.
Novavax, Inc. (NASDAQ:NVAX) Q4 2024 Earnings Call Transcript
Operator: Good morning and welcome to Novavax Fourth Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in listen-only mode.
Billionaire Hedge Funds
